We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Immortalized Neural Cell Lines to Aid Drug Discovery

By Biotechdaily staff writers
Posted on 23 May 2002
A library of immortalized human neural cell lines derived from the brain and spinal cord has been launched by CellFactors (Cardiff, UK) for use in a diverse range of pharmaceutical applications.

The company has perfected and patented a novel method of producing stable partially differentiated human cells for therapeutic purposes. More...
Although human and animal tissue culture-based systems have been the mainstay of biomedical research for many years, they do not reflect the physiology of native tissue. CellFactors says it can provide a near infinite supply of stable, replicating research-grade lines.

The company's lead product, Skeletex, is an orthobiologic material that induces the formation of new bone. A parallel development program, dedicated to neural disease therapy and controllable whole cells for implantation, is being developed initially for Parkinson's disease.

"Our expertise in neuroanatomy and molecular cell biology has made this commercial breakthrough possible,” said Dr. George Foster, one of the company's founders.





Related Links:
CellFactors

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.